<rss version="2.0">
<channel>
<title>Millipore Drug Discovery Services</title>
<link>http://Dominolb.millipore.com/corporate/pressroom.nsf/docs/aboutrss</link>
<description>Focus your research. White papers by scientific directors from Millipore’s Upstate Drug Discovery Services— delivered to your desktop— help you stay on top of trends in high-throughput screening/profiling services/multiplex testing.</description>
<copyright>Copyright 2009 Millipore Corporation</copyright>
<language>en</language>
<lastBuildDate>Mon, 23 Nov 2009 05:13:07 GMT</lastBuildDate>
<image>
<url>http://Dominolb.millipore.com/config.nsf/files/navigation_header/$file/mil_logo.gif</url>
<title>Millipore Drug Discovery Services</title>
<link>http://Dominolb.millipore.com/corporate/pressroom.nsf/docs/aboutrss</link>
</image>
<item>
<title><![CDATA[Battle at the Gates: Combating Mutant Kinases]]></title>
<description><![CDATA[New drugs that inhibit protein kinases have been successful in treating some 
cancer patients. When patients developed clinical resistance, scientists found 
they possessed undetected mutant forms of the targeted kinases. Learn how new 
research has identified the mechanisms by which resistance was achieved, the 
role of the "gatekeeper" in influencing inhibitor binding ability, and the 
disease-relevant mutations now available for high-throughput screening and 
enzymology studies.]]></description>
<link><![CDATA[http://www.millipore.com/techpublications/tech1/17150706]]></link>
<pubDate>
Thu, 23 Oct 2008 05:13:07 GMT
</pubDate>
</item>
</channel>
</rss>
